IPO · SDC
SmileDirectClub, Inc.
SmileDirectClub, Inc. (SDC) priced its initial public offering on Sep 13, 2019 at $23.00 per share, above its $19.00–$22.00 range, raising $1.35B. At the IPO price its market capitalization was about $8.85B. J.P. Morgan was lead-left underwriter, joined by Citigroup, Jefferies and UBS and others. Skadden, Arps advised the company and Latham & Watkins advised the underwriters.
SmileDirectClub, Inc. is a direct-to-consumer teledentistry company selling clear aligner treatment through a vertically integrated model. It targets people with malocclusion who have not been treated, offering an alternative to traditional in-office orthodontic care with braces or aligners.
- Status
- IPO
- Ticker
- SDC
- Priced
- Sep 13, 2019
- IPO price
- $23.00
- Price range
- $19.00–$22.00
- Raised
- $1.35B
- Market cap at IPO price
- $8.85B
- First filed
- Aug 16, 2019
- Underwriters
- J.P. Morgan, Citigroup, Jefferies, UBS, Credit Suisse, Guggenheim, Stifel, William Blair and Loop Capital
- Company counsel
- Skadden, Arps
- Underwriters' counsel
- Latham & Watkins
- Sector
- Healthcare
- Country / state
- TN
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
- Analyst notes on the filing
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Aug 16, 2019
- Latest amendment Sep 9, 2019
- Final prospectus (424B4) Sep 13, 2019
- All filings on EDGAR CIK 1775625
Other Healthcare IPOs in 2019
- Aesthetic Medical International Holdings Group LtdAIH · Oct 25, 2019 · $30M
- Progyny, Inc.PGNY · Oct 25, 2019 · $130M
- Exagen Inc.XGN · Sep 20, 2019 · $50.4M
- Envista Holdings CorpNVST · Sep 19, 2019 · $588.9M
- InMode Ltd.INMD · Aug 8, 2019 · $70M
- Castle Biosciences IncCSTL · Jul 26, 2019 · $64M